These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 9409257

  • 1. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.
    Horowitz JR, Rivard A, van der Zee R, Hariawala M, Sheriff DD, Esakof DD, Chaudhry GM, Symes JF, Isner JM.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2793-800. PubMed ID: 9409257
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium.
    van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM.
    Circulation; 1997 Feb 18; 95(4):1030-7. PubMed ID: 9054767
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries.
    Ku DD, Zaleski JK, Liu S, Brock TA.
    Am J Physiol; 1993 Aug 18; 265(2 Pt 2):H586-92. PubMed ID: 8368362
    [Abstract] [Full Text] [Related]

  • 7. Activation of Flk-1/KDR mediates angiogenesis but not hypotension.
    Malavaud B, Tack I, Jonca F, Praddaude F, Moro F, Ader JL, Plouët J.
    Cardiovasc Res; 1997 Nov 18; 36(2):276-81. PubMed ID: 9463639
    [Abstract] [Full Text] [Related]

  • 8. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium.
    Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F, Ziche M.
    J Biol Chem; 1998 Feb 13; 273(7):4220-6. PubMed ID: 9461619
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor causes pulmonary vasodilation through activation of the phosphatidylinositol-3-kinase-nitric oxide pathway in the late-gestation ovine fetus.
    Grover TR, Zenge JP, Parker TA, Abman SH.
    Pediatr Res; 2002 Dec 13; 52(6):907-12. PubMed ID: 12438669
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor receptor-2-mediated mitogenesis is negatively regulated by vascular endothelial growth factor receptor-1 in tumor epithelial cells.
    Dunk C, Ahmed A.
    Am J Pathol; 2001 Jan 13; 158(1):265-73. PubMed ID: 11141500
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway.
    Shen BQ, Lee DY, Zioncheck TF.
    J Biol Chem; 1999 Nov 12; 274(46):33057-63. PubMed ID: 10551875
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.
    Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu JS, Isner JM.
    Am J Pathol; 1998 Aug 12; 153(2):381-94. PubMed ID: 9708799
    [Abstract] [Full Text] [Related]

  • 15. Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively.
    Zeng H, Sanyal S, Mukhopadhyay D.
    J Biol Chem; 2001 Aug 31; 276(35):32714-9. PubMed ID: 11435426
    [Abstract] [Full Text] [Related]

  • 16. KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF.
    Li B, Ogasawara AK, Yang R, Wei W, He GW, Zioncheck TF, Bunting S, de Vos AM, Jin H.
    Hypertension; 2002 Jun 31; 39(6):1095-100. PubMed ID: 12052848
    [Abstract] [Full Text] [Related]

  • 17. Effects of coronary artery disease on expression and microvascular response to VEGF.
    Métais C, Li J, Li J, Simons M, Sellke FW.
    Am J Physiol; 1998 Oct 31; 275(4):H1411-8. PubMed ID: 9746492
    [Abstract] [Full Text] [Related]

  • 18. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
    Chang YS, Munn LL, Hillsley MV, Dull RO, Yuan J, Lakshminarayanan S, Gardner TW, Jain RK, Tarbell JM.
    Microvasc Res; 2000 Mar 31; 59(2):265-77. PubMed ID: 10684732
    [Abstract] [Full Text] [Related]

  • 19. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance.
    Yang R, Thomas GR, Bunting S, Ko A, Ferrara N, Keyt B, Ross J, Jin H.
    J Cardiovasc Pharmacol; 1996 Jun 31; 27(6):838-44. PubMed ID: 8761851
    [Abstract] [Full Text] [Related]

  • 20. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR.
    Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, Galeotti T.
    J Biol Chem; 2002 Feb 01; 277(5):3101-8. PubMed ID: 11719508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.